Efficacy and Safety of Disitamab Vedotin Combined With Sintilimab
Clinical trial NCT05928897 · UNKNOWN
Trial details
- NCT number
- NCT05928897
- Sponsor
- Xiangya Hospital of Central South University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-01
- Primary completion
- 2025-07-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.